Provided by Tiger Trade Technology Pte. Ltd.

HBM HOLDINGS-B

13.860
+0.3202.36%
Volume:9.94M
Turnover:138.86M
Market Cap:12.04B
PE:126
High:14.360
Open:13.580
Low:13.580
Close:13.540
52wk High:17.070
52wk Low:9.460
Shares:869.00M
HK Float Shares:869.00M
Volume Ratio:0.95
T/O Rate:1.14%
Dividend:- -
Dividend Rate:- -
EPS(LYR):0.110
ROE:23.97%
ROA:10.88%
PB:3.67
PE(LYR):126.00
PS:8.57

Loading ...

HBM Holdings Schedules Board Meeting to Review Interim Results

Reuters
·
Aug 17

HBM Holdings (SEHK:2142) Names Metabolic Chief And Partners With Sinopharm, Is It Fully Priced?

Simply Wall St.
·
Aug 09

Hong Kong Stock Movers: HBM Holdings-B Surges Over 7% in Early Trading on First-Half Revenue Growth and Profitability, Following Strategic Partnership with Sinopharm

Stock News
·
Aug 07

HBM Holdings Adds 0.80 Million Shares from Option Exercises, Lifting Total Issued to 900.98 Million

Bulletin Express
·
Aug 06

Harbour BioMed Names Bob Zhang President of Metabolic Disease Franchise

Reuters
·
Aug 06

Harbour Biomed Appoints DR. Bob Zhang as President of Metabolic Disease Franchise to Accelerate Global Development of Innovative Therapies

THOMSON REUTERS
·
Aug 06

Is HBM Holdings (SEHK:2142) Undervalued As Its Sinopharm Biologic Drug Consortium Takes Shape?

Simply Wall St.
·
Jul 29

HBM Holdings-B (02142) Forms Strategic Alliance with China National Pharmaceutical Group to Establish Joint Innovation Body

Stock News
·
Jul 27

Harbour Biomed and Sinopharm Enter Strategic Collaboration to Establish Innovation R&D Consortium

THOMSON REUTERS
·
Jul 27

Hbm Holdings - Enters Strategic Collaboration with China National Pharmaceutical Group on Biologics R&D

THOMSON REUTERS
·
Jul 27

HBM Holdings Enters Strategic Biologics R&D Collaboration with Sinopharm

Reuters
·
Jul 27

HBM Holdings Expects H1 Profit of Up to $67 Million

MT Newswires Live
·
Jul 24

HBM Holdings Expects HY Revenue $120 Million-$125 Million

Reuters
·
Jul 24

HBM Holdings Signals Strong First-Half 2026: Revenue to Rise c.20% to Up to US$125 Million; Profit Seen at US$62-67 Million

Bulletin Express
·
Jul 24

HBM Holdings-B (02142) Expects Mid-Year Net Profit Between $62 Million and $67 Million

Stock News
·
Jul 24

Press Release: Harbour Biomed Announces Positive Profit Alert for 2026 Interim Results, Marking Seventh Consecutive Profitable Half-year as Platform-based Advantages Drive Sustainable Growth

Dow Jones
·
Jul 24

Hbm Holdings - Expects Revenue of Us$120 Mln-us$125 Mln for Six Months Ended 30 June 2026

THOMSON REUTERS
·
Jul 24

Nona Biosciences Enters Research Collaboration with the Medical University of Vienna to Advance Fully Human Antibody Development for Infectious Diseases

THOMSON REUTERS
·
Jul 23

Is HBM Holdings (SEHK:2142) Fully Valued After Its Asthma IND Approval?

Simply Wall St.
·
Jul 21

HBM Holdings's Asthma Drug Candidate Secures China's Approval

MT Newswires Live
·
Jul 16